Liu L - Search Results

1

Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G. Zanchetti A, et al. Among authors: liu l. J Hypertens. 2014 Sep;32(9):1888-97. doi: 10.1097/HJH.0000000000000254. J Hypertens. 2014. PMID: 24979303 Clinical Trial.

2

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A; FEVER Study Group. Liu L, et al. Among authors: liu g. J Hypertens. 2005 Dec;23(12):2157-72. doi: 10.1097/01.hjh.0000194120.42722.ac. J Hypertens. 2005. PMID: 16269957 Clinical Trial.

3

Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study.

Zhang Y, Zhang X, Liu L, Zanchetti A; FEVER Study Group. Zhang Y, et al. Among authors: liu l. J Hypertens. 2010 Oct;28(10):2016-25. doi: 10.1097/HJH.0b013e32833cd338. J Hypertens. 2010. PMID: 20625319 Clinical Trial.

4

Higher cardiovascular risk and impaired benefit of antihypertensive treatment in hypertensive patients requiring additional drugs on top of randomized therapy: is adding drugs always beneficial?

Zhang Y, Zhang X, Liu L, Wang Y, Tang X, Zanchetti A; FEVER Study Group. Zhang Y, et al. Among authors: liu l. J Hypertens. 2012 Nov;30(11):2202-12. doi: 10.1097/HJH.0b013e3283582eec. J Hypertens. 2012. PMID: 22990352 Clinical Trial.

5

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Wang H, Zhang Y, Zhang X, Guan TR, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Erdine S, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G. Zanchetti A, et al. Among authors: liu l. J Hypertens. 2014 Sep;32(9):1741-50. doi: 10.1097/HJH.0000000000000253. J Hypertens. 2014. PMID: 24979302 Review.

6

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G; ESH-CHL-SHOT trial investigators. Zanchetti A, et al. Among authors: liu l. J Hypertens. 2016 Mar;34(3):393-6. doi: 10.1097/HJH.0000000000000853. J Hypertens. 2016. PMID: 26780185 No abstract available.

7

Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature.

Liu L, Wang Z, Gong L, Zhang Y, Thijs L, Staessen JA, Wang J. Liu L, et al. Hypertens Res. 2009 Nov;32(11):1032-40. doi: 10.1038/hr.2009.139. Epub 2009 Oct 2. Hypertens Res. 2009. PMID: 19798097 Review.

8

Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.

Zhang Y, Zhang X, Liu L, Zanchetti A; FEVER Study Group. Zhang Y, et al. Among authors: liu l. Eur Heart J. 2011 Jun;32(12):1500-8. doi: 10.1093/eurheartj/ehr039. Epub 2011 Feb 22. Eur Heart J. 2011. PMID: 21345850 Clinical Trial.

9

Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China.

Feldman RD, Liu L, Wu Z, Zhang Y, Yu X, Zhang XH. Feldman RD, et al. Among authors: liu l. J Clin Hypertens (Greenwich). 2017 Mar;19(3):256-264. doi: 10.1111/jch.12912. Epub 2016 Oct 26. J Clin Hypertens (Greenwich). 2017. PMID: 27781379 Free PMC article.

10

Termination of the ESH-CHL-SHOT trial.

Liu L, Mancia G. Liu L, et al. J Hypertens. 2020 Dec;38(12):2542-2543. doi: 10.1097/HJH.0000000000002660. J Hypertens. 2020. PMID: 33031181 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,562 results

Search Page

Filters